Salwan Pharmacy Limited - Accounts to registrar (filleted) - small 18.2

Salwan Pharmacy Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v20.1.0.635 SC244685 Board of Directors 1.6.18 31.5.19 31.5.19 true false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC2446852018-05-31SC2446852019-05-31SC2446852018-06-012019-05-31SC2446852017-05-31SC2446852017-06-012018-05-31SC2446852018-05-31SC244685ns15:Scotland2018-06-012019-05-31SC244685ns14:PoundSterling2018-06-012019-05-31SC244685ns10:Director12018-06-012019-05-31SC244685ns10:PrivateLimitedCompanyLtd2018-06-012019-05-31SC244685ns10:SmallEntities2018-06-012019-05-31SC244685ns10:AuditExempt-NoAccountantsReport2018-06-012019-05-31SC244685ns10:SmallCompaniesRegimeForDirectorsReport2018-06-012019-05-31SC244685ns10:SmallCompaniesRegimeForAccounts2018-06-012019-05-31SC244685ns10:FullAccounts2018-06-012019-05-31SC24468512018-06-012019-05-31SC244685ns10:Director22018-06-012019-05-31SC244685ns10:CompanySecretary12018-06-012019-05-31SC244685ns10:RegisteredOffice2018-06-012019-05-31SC244685ns5:CurrentFinancialInstruments2019-05-31SC244685ns5:CurrentFinancialInstruments2018-05-31SC244685ns5:Non-currentFinancialInstruments2019-05-31SC244685ns5:Non-currentFinancialInstruments2018-05-31SC244685ns5:ShareCapital2019-05-31SC244685ns5:ShareCapital2018-05-31SC244685ns5:SharePremium2019-05-31SC244685ns5:SharePremium2018-05-31SC244685ns5:CapitalRedemptionReserve2019-05-31SC244685ns5:CapitalRedemptionReserve2018-05-31SC244685ns5:RetainedEarningsAccumulatedLosses2019-05-31SC244685ns5:RetainedEarningsAccumulatedLosses2018-05-31SC244685ns5:NetGoodwill2018-06-012019-05-31SC244685ns5:PlantMachinery2018-06-012019-05-31SC244685ns5:NetGoodwill2018-05-31SC244685ns5:NetGoodwill2019-05-31SC244685ns5:NetGoodwill2018-05-31SC244685ns5:PlantMachinery2018-05-31SC244685ns5:PlantMachinery2019-05-31SC244685ns5:PlantMachinery2018-05-31SC244685ns5:AdditionsToInvestments2019-05-31SC244685ns5:RevaluationsIncreaseDecreaseInInvestments2019-05-31SC244685ns5:CostValuation2019-05-31SC244685ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-05-31SC244685ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-05-31SC244685ns5:Secured2019-05-31SC244685ns5:Secured2018-05-31
REGISTERED NUMBER: SC244685 (Scotland)













FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2019

FOR

SALWAN PHARMACY LIMITED

SALWAN PHARMACY LIMITED (REGISTERED NUMBER: SC244685)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2019










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SALWAN PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2019







DIRECTORS: N Salwan
N Aggarwal





SECRETARY: N Aggarwal





REGISTERED OFFICE: 4 Lynedoch Place
Glasgow
G3 6AB





REGISTERED NUMBER: SC244685 (Scotland)





ACCOUNTANTS: Bannerman Johnstone Maclay
213 St Vincent Street
Glasgow
G2 5QY

SALWAN PHARMACY LIMITED (REGISTERED NUMBER: SC244685)

BALANCE SHEET
31 MAY 2019

2019 2018
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 490,552 564,371
Tangible assets 5 45,251 50,421
Investments 6 141,433 -
677,236 614,792

CURRENT ASSETS
Stocks 128,316 103,731
Debtors 7 1,043,587 1,112,209
Cash at bank and in hand 223,803 192,045
1,395,706 1,407,985
CREDITORS
Amounts falling due within one year 8 991,632 945,697
NET CURRENT ASSETS 404,074 462,288
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,081,310

1,077,080

CREDITORS
Amounts falling due after more than one year 9 1,166,920 1,282,183
NET LIABILITIES (85,610 ) (205,103 )

CAPITAL AND RESERVES
Called up share capital 3 3
Share premium 479,001 479,001
Capital redemption reserve 1 1
Retained earnings (564,615 ) (684,108 )
SHAREHOLDERS' FUNDS (85,610 ) (205,103 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act
2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394
and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

SALWAN PHARMACY LIMITED (REGISTERED NUMBER: SC244685)

BALANCE SHEET - continued
31 MAY 2019


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 May 2020 and were signed
on its behalf by:





N Salwan - Director


SALWAN PHARMACY LIMITED (REGISTERED NUMBER: SC244685)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2019


1. STATUTORY INFORMATION

Salwan Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered
number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

The directors renegotiated the company's banking facilities during the year and consider it appropriate to prepare the
financial statements on the going concern basis.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2016, is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost, 25% on cost, 15% on reducing balance and 10% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 30 (2018 - 25 ) .

SALWAN PHARMACY LIMITED (REGISTERED NUMBER: SC244685)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2019


4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 June 2018
and 31 May 2019 1,252,190
AMORTISATION
At 1 June 2018 687,819
Charge for year 73,819
At 31 May 2019 761,638
NET BOOK VALUE
At 31 May 2019 490,552
At 31 May 2018 564,371

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 June 2018 216,542
Additions 3,391
Disposals (2,000 )
At 31 May 2019 217,933
DEPRECIATION
At 1 June 2018 166,121
Charge for year 8,561
Eliminated on disposal (2,000 )
At 31 May 2019 172,682
NET BOOK VALUE
At 31 May 2019 45,251
At 31 May 2018 50,421

SALWAN PHARMACY LIMITED (REGISTERED NUMBER: SC244685)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2019


6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
Additions 138,600
Revaluations 2,833
At 31 May 2019 141,433
NET BOOK VALUE
At 31 May 2019 141,433

Cost or valuation at 31 May 2019 is represented by:

Other
investments
£   
Valuation in 2019 2,833
Cost 138,600
141,433

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Trade debtors 148,687 228,705
Amounts owed by related undertakings 486,092 15,176
Other debtors 408,808 868,328
1,043,587 1,112,209

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Bank loans and overdrafts 147,064 141,427
Trade creditors 606,145 493,093
Amounts owed to related undertakings 11,824 -
Taxation and social security 186,613 203,345
Other creditors 39,986 107,832
991,632 945,697

SALWAN PHARMACY LIMITED (REGISTERED NUMBER: SC244685)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2019


9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2019 2018
£    £   
Bank loans 1,166,920 1,282,183

10. SECURED DEBTS

The following secured debts are included within creditors:

2019 2018
£    £   
Bank overdraft - 6
Bank loans 1,313,984 1,423,604
1,313,984 1,423,610